Clinical development of platinum complexes in cancer therapy: an historical perspective and an update
- 1 September 1998
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (10) , 1522-1534
- https://doi.org/10.1016/s0959-8049(98)00224-x
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- 272 A phase I study of JM-216 with concomitant radiation therapy for patients (pts) with malignancies of the chestLung Cancer, 1997
- Cycloplatam: A novel platinum compound exhibiting a different spectrum of anti-tumour activity to cisplatinEuropean Journal Of Cancer, 1995
- Preliminary phase II trial of oxaliplatin (L-OHP) in malignant astrocytomasEuropean Journal Of Cancer, 1993
- Phase II study of oxaliplatin (L-OHP) in patients with advanced non small cell lung cancer (NSCLC): Preliminary resultsEuropean Journal Of Cancer, 1993
- Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complexEuropean Journal Of Cancer, 1993
- Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lungEuropean Journal Of Cancer, 1993
- Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest oncology group studyEuropean Journal of Cancer and Clinical Oncology, 1991
- Preclinical antitumor and toxicologic profile of carboplatinCancer Treatment Reviews, 1985
- New platinum complexes in clinical trialsCancer Treatment Reviews, 1983
- Anti-tumour platinum complexes : relationships between chemical properties and activityBiochimie, 1978